chrisvoncsefalvay/vaers-outcomes huggingface dataset:
experienced some type of discomfort between the shoulder blades; Chills; patient was achy and tired; her muscles ache/feel achy her body aches; patient was achy and tired; her muscles ache/feel achy her body aches; patient was achy and tired; her muscles ache/feel achy her body aches; she has pressure and lower back, rib, back and chest area it felt like somebody was hitting in her back; it was terrible it was so painful; she has pressure and lower back, rib, back and chest area; she has pressure and lower back, rib, back and chest area it felt like somebody was hitting in her back; it was terrible it was so painful; she has pressure and lower back, rib, back and chest area it felt like somebody was hitting in her back; This is a spontaneous report from a contactable consumer, or other non-healthcare professional (patient) via Pfizer-sponsored program.    A 62-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0173, Expiry date: not reported), via intramuscular route of administration, administered in arm right on 08Jun2021 at 09:00 as dose 2, single for COVID-19 immunization. Medical history included hypersensitivity take allergy medicines over the counter. The patient concomitant medications included allergy medicines (unspecified name) over the counter. No other vaccine was administered 4 weeks prior the covid vaccine. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0173, Expiry date: not reported) via an unspecified route of administration on 08May2021 at 09:00 as dose 1, single for COVID-19 immunization and the next day she experienced that her lymph node under her right armpit became the size of the boiled egg and that the nurse injected the vaccine on the backside of the arm which was what she attributed to the swelling of the lymph nodes. On 08Jun2021, it was like might 15 to 10 minutes after got second shot, the patient experienced some type of discomfort between the shoulder blades, chills, patient was achy and tired; her muscles ache/feel achy her body aches, she has pressure and lower back, rib, back and chest area it felt like somebody was hitting in her back; it was terrible it was so painful. The patient received the second dose of the vaccine yesterday, so that was on Tuesday on 08Jun2021 and she got the vaccine yesterday at 9.00 and she experienced some type of discomfort between the shoulder blades she mentioned that it was all like the foot was pushing in between them and it got worse and later on the discomfort eased but still present and also to add to that she mentioned that last night she felt chills. The patient stated that she had feel achy her body aches and earlier she had pressure and her lower back, rib, back and chest area it felt like pressure feel like somebody was hitting in her back and it was gone a while now but yesterday it was terrible it was so painful. The patient did not receive treatment for the events. The outcome of the event was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
This spontaneous case reported by a consumer, describes the occurrence of pain (soreness), myalgia (muscle aches) and chills in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced pain (soreness), myalgia (muscle aches) and chills. At the time of the report, pain (soreness), myalgia (muscle aches) and chills outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information provided. Reporter did not allow further contact.
The Pt presents complaining of throat tightness, cough, and dysphagia 10 minutes following 2nd dose of Pfizer vaccine to left deltoid. Pt has a Hx of UC, endometriosis, and seasonal allergies for which she takes 1600mg BID Mesalamine, Vyfemla 0.425mg QD, and 180mg Allegra. Pt states that she took Allegra prior to her vaccine. She reports allergy to hydrocodone and confirms skin rash as the reaction to that medication. Currently she denies any itching of the skin or swelling of the lips/face/eyes. She also denies dizziness, numbness, tingling, or nausea. Epinephrine dose prepped and ready should condition worsen or anaphylaxis develop. Upon observation and oral rehydration Pt?s condition remained unchanged with persistent cough and throat tightness. EMS was called and care was transferred to fire and rescue. Pt was transferred to the hospital.
Swollen (L) arm, warm to touch. Treatment: pt to apply ice, SEPTRA Rx and BENADRYL Rx,
Day of vaccine, patient complained of vomiting/fever/body aches. On 8/19/10, patient presented to pharmacy with 6 in. oval red rash/warmth around injection site.
Mom states on 10-20-09 approx 30 min. after breakfast child developed hives on face, arms, trunk of body.  Hives lasted about 14 1/2 hrs and then goes away.  Returned in like manner after every meal.  Has occurred for eight days.  Pt went to see PMD who prescribed ZYRTEC.
Called this clinic complaining of pain and swelling at the site of the injection as well as  fever.
This spontaneous report as received from a pharmacist refers to a 10 years old female patient. The patients mother stated that the patient was vaccinated with one dose of 1.0 ml GARDASIL (lot# unknown) today(07-SEP-2012) at her physician's office. No other co-suspects were reported. No concomitant medications were reported. The mother reported that while the physician was examined the patient and her sister, the physician picked up two syringes from a tray and administered both of them to the patient. The mother reports that when she inquired what the patient received, the physician was informed by his nurse that both of the syringes contained one dose of GARDASIL. Both doses of GARDASIL were administered into the patient's left arm. The mother stated that the patient did not exhibit any redness or other adverse effects to her injection site; she also reported that the patient had not reported any adverse effect. The patient sought medical attention by consulted pharmacist. Additional information has been requested.
Registered notified by HCA that she heard client had reaction to shots. Registered nurse called mother and she reports client did have a problem post shots and apologies for not alerting agency. She does have copies of paperwork and will bring to agency. Mother reports one week post vax, ran 104 temp. This lasted for 1.5 weeks. Two weeks post vax, client started having bowel troubles and was taken to emergency room with possible bowel obstruction. Two weeks later, severe bruising noted on foot, waist, groin, where anything was tight on skin. On 02/04, client was taken to hospital with low platelets. Was negative for cancer and mom states doctor is not sure if shots were cause of idiopathic thrombocytopenic purpura, but could be. Client is currently recovering.
right axillary lymphadenopathy 24-36 hours post shot that is still present right flank pain morning after the shot with duration of 6 hours. on/off fever for 1st 24 hours
BODY ACHES; LITTLE SORE ARM; FEVER; VERY TIRED; This spontaneous report received from a patient concerned a 59 year old. The patient's height, and weight were not reported. The patient's concurrent conditions included: fibromyalgia, depression, anxiety, pollen allergy, and sulfa allergy. The patient was previously treated with covid-19 vaccine ad26. cov2. s for prophylactic vaccination with no side effects, dose series 1.   The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 182A09 expiry: UNKNOWN) dose was not reported, 1 total, dose series 2,  administered at right arm on 06-NOV-2021 for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date in NOV-2021, the patient experienced body aches, little sore arm, fever and was very tired after getting the booster dose. Laboratory data included: Body temperature (NR: not provided) 102 F. On 12-NOV-2021, Laboratory data included: Body temperature (NR: not provided) 100 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from little sore arm on NOV-2021, and had not recovered from fever, body aches, and very tired. This report was non-serious.
My throat closed up, I was covered in hives, and I could barely breathe. I went to Emergency Center. I was prescribed Epinephrine, Prednisone, Benadryl, Famotidine, and I also took OTC Cetirizine. I was sent home with medication. When I ran out of the medication, my symptoms flared up again. I went to the ER several times.
contracted the covid virus in November of 2021. Symptoms included sinus infection with drainage, headache, fatigue, loss of smell and taste.
received first covax on 27Feb and then tested positive for virus; received first covax on 27Feb and then tested positive for virus; This is a spontaneous report from a contactable consumer via a Pfizer-sponsored program. A patient of unspecified age and gender received first dose of BNT162B2 (COVID-19 Vaccine, formulation: solution for injection), via an unspecified route of administration on 27Feb2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The consumer reported that the patient received first vax on 27Feb2021 and then tested positive for virus. The patient is supposed to get the second vax on 20Mar2021 and is asking how do they proceed. Outcome of events was unknown.  Information on the lot/batch number has been requested.
Administered  bivalent FP 12 yrs-adult booster (Pfizer) when patient was due for another primary dose. Patient was immunocompromise.
Death on 4-5-21 the day after the shot.  Bloody nose during that day
edema 2 days p/vax 6AUg97 w/redness;
2 Oct Tremors in anterior left leg reaching to calf. Tremors lessened slightly on 16 Oct 21. Still experience throughout the day, though not constantly. 15  Oct 21. Nosebleed that would not be staunched for over 60 minutes. No external trauma. Do not get NOSEBLEEDS period 15 Oct 21 New sharp pain right ring finger that is intermittent. Have never experienced pain in hands/fingers except from external trauma of which there has been none in this case.
This spontaneous report as received from a Licensed Vocational Nurse, refers to two patients of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies were not provided. On an unknown date, the patients were vaccinated with a dose of VARIVAX, 0.5 ml, subcutaneously, Lot # J005726 and expiration date on 08-MAY-2014 (also reported as 08-APR-2014). Co-suspect therapy and concomitant medications were not provided. It was reported that two unspecified patients were administered doses of VARIVAX that underwent a temperature excursion. No adverse effect was reported. Additional information has been requested.
Chest Pain, Left arm pain. Shortness of Breath on Exertion. Exersise induced Tachycardia HR 160BPM; HTN BP 190/110; Reported to GP on 05/06/2021. Followed up ECG - sinus rhythm; FBC - Troponin.  <0.02 ng/ml; CT Calcium score  0; Advised it would spontaneously resolve; Re-presented to GP in September 2021 and referred to Cardiologist for 10/25/21; Symptoms have continued until 10/23/21; Presented to ED with 8/10 chest pain; ECG = normal SR; FBC Troponin.  <0.02 ng/ml.
The initial symptom I felt was burning in my nose. It felt like I had fire in my nose. I took a COVID-19 test at home on February 20, 2023. The result was positive. I also had body aches, headache, runny nose, and general feeling of malaise. On February 21, 2023, I went to my doctor. He prescribed Ivermectin. On February 25, 2023, I was not feeling any better. I went back to the doctor. He prescribed Paxlovid. I started taking it that day. I started feeling a little better. I tested for COVID-19 again on March 2, 2023. I was still positive. I went back to the doctor. He said that it would take a while to feel better and did not give me any other medications. I still have a lingering cough. I finally tested negative for COVID-19 on March 10, 2023.
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, chills/ fatigue/ swollen glands Narrative:
Diarrea 4-5 times a day still on July 7th Diarrea 3 times a day. Even with Imodium being taken 3 days.
Site pain soreness, woke up with 100.7 fever, body aches, chill, nausea, headache and extreme fatigueand felt like this for 3 full days. Then 7 days later awoke with extreme headache behind left eye, sensitivity to light, sensitive/sore spot on top of head, exhausted but trouble sleeping, upset stomach.
Became ill; had to go to the hospital; dizziness/lightheadedness; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on 10Feb2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient had his first COVID vaccine (later confirmed) on Wednesday and he was supposed to have his second shot. It was reported that "my first shot was if you got it in the book, my first shot was 10Feb2021 and my second shot was due for 02Mar2021." The patient became ill and had to go to the hospital. It was reported that the patient missed his second dose schedule on 02Mar2021, because he had dizziness and lightheadedness, and would like to make an appointment again. The outcome of the events was unknown   Information about the Lot/batch number has been requested.
Information has been received from an advanced registered nurse practitioner concerning an 18 year old female patient with history of fainted in the past after seeing needles who on 11-JAN-2010 was vaccinated with a first 0.5 ml dose of GARDASIL. The nurse practitioner reported that "as she was withdrawing the needle from the patient's arm, she went limp and went back on exam table, then seized loss of consciousness, came to conscious and reported seizure activity. She left in ambulance to a hospital (stayed in hospital was unknown) and she was stable. Neurological evaluation was negative. Follow up information has been received from an advanced registered nurse practitioner concerning the patient on 11-JAN-2009 was vaccinated with the first dose of GARDASIL (Lot # 661954/1131X), 0.5 ml, IM. The patient did not received any concomitant vaccinations at that time. When the registered nurse withdrew the GARDASIL needle from the patient. the patient became limp and had a tonic- clonic seizure with loss of consciousness that lasted about 60 seconds. The patient regained consciousness and had another tonic- clonic seizure with loss of consciousness that lasted about 40 seconds. The patient regained consciousness and was pale and diaphoretic. Oxygen was administered and the patient's blood pressure was 80/40. The paramedics were called to the office and the patient was transported to the Emergency Room (ER) at a hospital. At the time the patient refused intravenous (IV) therapy. Blood laboratory tests were drawn in the ER and the patient fainted. The patient regained consciousness and recovered. The patient was not admitted to the hospital; she was kept in the hospital for one hour and was sent home. On 12-JAN-2010 during a conversation with the registered nurse the patient reported that she had recovered. The patient had a scheduled appointment to see the advanced registered nurse practitioner on 14-JAN-2009 for routine physical. Upon internal review tonic-clonic seizure was considered an other important medical event. Additional information is not expected.
Patient has been rubbing a fever of 100.9, drowsiness, lack of appetite, weak, whole body is hot.
pt recvd vax; w/in 15 mins became very dizzy & diaphoretic;BP 90/60;seen at hosp er;EKG ok, no problems noted;no oth local or systemic sxs devel;
EMT Bustamante noted the client was splashing water on her face and hugging her caretaker in the observation area. EMT Bustamante approached the client and asked how she was feeling. The client reported anxiety to EMT Bustamante at 1:34PM. EMT Bustamante escorted the client and her caretaker outside the building and she was seated on a bench. Vitals obtained at 1:34 PM were as follows: BP 130/90, HR 110, and O2 99%. 2 RN's responded at 1:40PM. The client at that time stated she was having "anxiety." 2 RN's left the scene. At 1:49 PM the client stated she "couldn't breathe." RN responded and provided an emesis bag to the client. The client started using the emesis bag to breathe into. RN counted with the client to slow her breathing down. At 1:50PM the client stated she was "starting to feel better." RN played a 3 minute meditation for the client. At 1:53 PM the client was provided an ice pack on the back of her neck. Vitals obtained at 1:55PM were as follows BP138/82, HR 115, and O2 99%. The client noted frustration about her anxiety and increased heart rate. The client also noted "weakness" in her right arm. At 2:03PM the client received emotional support from her caretaker via a hug. At 2:10 the client stated she was "feeling better and almost ready to leave." The client took 2 puffs of her Albuterol inhaler around 2:12. The client stated she uses the inhaler PRN for a history of asthma. The client also reports a history of anxiety which is not controlled with medication. At 2:14PM vitals obtained were as follows: BP 128/84, HR 127, and O2 99%. The client subsequently stood up and stood underneath a tree in the shade. The client received another emotional support hug, was provided a new ice pack, and continued to splash water on her face. RN offered to call EMS services, and the client declined. RN educated the client and her caretaker of s/s of anaphylaxis, when to seek EMS, and to follow up with PCP regarding anxiety symptoms, and V-safe. The client voiced understanding of this. RN escorted the client out of the vaccination site. The client ambulated unassisted with a steady gait. RN visualized the client entering the vehicle to be driven home by her caretaker at 2:27 PM.
pt found in crib not breathing, no pulse; given CPR with return of respiration and heart beat; Annual follow up states has neurologic disorder.
itchiness at the injection site; Bruise appearance spot at injection site; black, blue and red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at the injection site), VACCINATION SITE BRUISING (Bruise appearance spot at injection site) and SKIN DISCOLOURATION (black, blue and red) in a 95-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at the injection site), VACCINATION SITE BRUISING (Bruise appearance spot at injection site) and SKIN DISCOLOURATION (black, blue and red). At the time of the report, VACCINATION SITE PRURITUS (itchiness at the injection site) and VACCINATION SITE BRUISING (Bruise appearance spot at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Treatment details included not provided.   Reporter did not allow further contact
pt reports that w/in 2-3 hrs of receiving vax exp muscle soreness, chills, aches & t102; seen by MD felt probably flu;
very sore arm; body ache; body chills; nausea; headache; This is a spontaneous report from contactable consumer. A 71 years female consumer (patient) reported for herself that she received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date single dose for COVID-19 immunisation. Medical history and concomitant drugs were not provided. The patient reported to have a very sore arm, body ache, body chills, nausea, headache, & 'about every one of the possible side effects'. The outcome of the event was unknown.  No follow-up attempts were needed. Information on Lot/batch number cannot be obtained.
Information has been received from a physician concerning her daughter with no drug reaction/allergies who on 07-AUG-1998 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). There were no concomitant medications. In June 2006, the patient was diagnosed with Crohn's disease. She has been receiving prednisone and azathioprine sodium (IMURAN) for the treatment of Crohn's disease. In October 2006, the patient showed a negative varicella zoster virus titer. Unspecified medical attention was sought. There was no product quality compliant. Additional information has been requested.
Fever; Discomfort; This is a spontaneous report from a contactable physician via Pfizer sales representative. A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date at single dose for immunization. Medical history included asplenia. The patient's concomitant medications were not reported. It was reported that the patient experienced fever and discomfort on an unspecified date after given pneumococcal 13-val conj vac (dipht crm197 protein). Outcome of the events was unknown.  Information on the batch number has been requested.
Please note that I had put down the wrong date but can change it.  The date was 09/01/2009. Within a few minutes of rcvng the vaccines, we were waiting outside the peds. office to speak to him and my daughter said she could not see and that everything had gone black.  She appeared to be very pale and when I picked her up, she felt limp to me.  The ped. and I rushed her back into the exam room where he laid her on her back and elevated her feet.  My daughter complained of her heart hurting her (I could feel it beating very quickly) and her stomach hurting her.  She was asking me to press on both her heart and stomach to help ease the pain.  The ped. asked his assistant to get smelling salts which were administered under my daughters nose.  Within 5-7 minutes, she appeared to have color coming back to her face and said that the pain in her stomach and heart had subsided.  Her vision came back at the time too.
5/21/12 Pt. complaint that vaccine injection hurt, some bleeding afterward - pressure applied x 1 minute, bandaid applied, and she returned to work. (11:40 AM) 5/22 will see ER physician today - c/o not able to move (R) arm, weak.
Information has been received from a registered nurse concerning a 12 month old female who on 02-JUN-1999 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On 07-Jun-1999 (5 days later) the patient had a rash all over her body. The outcome was reported as recovered. No other information. There was no product quality complaint. Additional information has been requested.
The patient states he experienced hives from his shins down when he first received the vaccine. Now he is experiencing itching at night time only on his legs.
I woke up a week later and my stomach was tender to the touch . I went to the the Doctor because of the pain, and my blood pressure was very elevated and now I'm on 2 blood pressure medications
The pt experienced shaking several times during the night of the vax, then had several convulsions and was admitted to the hospital for evaluation. The pt is on medication until the final test results are in.
Pt recv vax on 1/8/99; on 1/15/99 pt exp abdomen pain, diarrhea x 1-2 day